To the editor:I read with great interest the recent article by Pan et al1 in a recent issue of your esteemed joal.The article is highly thought provoking.Interestingly,the past few years have seen the emergence of a number of novel new agents for successful amelioration of the symptoms and pain associated with cyclophospamide induced hemorrhagic cystitis (CIHC) as well as overactive bladder.